Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 285
8
Diseases
19
Unique genes
0.215
Avg. similarity score
Benign neonatal-infantile seizures
Most-connected disease (5 links)
Disease
Searched: Epileptic encephalopathy, early infantile, 11
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Epileptic encephalopathy, early infantile, 11
Benign neonatal-infantile seizures
Benign infantile epilepsy
Benign neonatal epilepsy
Epilepsy of infancy with migrating focal seizures
Hemiplegia
Epileptic encephalopathy, early infantile, 34
Woodhouse sakati syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Benign neonatal-infantile seizures | 5 | 5 | 2 |
| Benign infantile epilepsy | 4 | 4 | 6 |
| Benign neonatal epilepsy | 4 | 4 | 4 |
| Epilepsy of infancy with migrating focal seizures | 4 | 4 | 9 |
| Epileptic encephalopathy, early infantile, 11 | 4 | 4 | 1 |
| Hemiplegia | 3 | 3 | 5 |
| Epileptic encephalopathy, early infantile, 34 | 1 | 1 | 1 |
| Woodhouse sakati syndrome | 1 | 1 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SCN2A | 6 / 8 | Benign infantile epilepsy, Benign neonatal epilepsy, Benign neonatal-infantile seizures, Epilepsy of infancy with migrating focal seizures and 2 more |
| KCNQ2 | 4 / 8 | Benign infantile epilepsy, Benign neonatal epilepsy, Benign neonatal-infantile seizures, Epilepsy of infancy with migrating focal seizures |
| KCNQ3 | 2 / 8 | Benign infantile epilepsy, Benign neonatal epilepsy |
| METTL8 | 2 / 8 | Hemiplegia, Woodhouse sakati syndrome |
| SLC12A5 | 2 / 8 | Epilepsy of infancy with migrating focal seizures, Epileptic encephalopathy, early infantile, 34 |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Phase 0 - rapid depolarisation | Reactome | 3 / 44 | 43.1× | 4.27e-5 | 9.65e-4 ✓ sig. |
| Thyroid hormone synthesis | KEGG | 3 / 75 | 25.3× | 2.11e-4 | 3.42e-3 ✓ sig. |
| Cholinergic synapse | KEGG | 3 / 115 | 16.5× | 7.41e-4 | 9.03e-3 ✓ sig. |
| Voltage gated Potassium channels | Reactome | 2 / 43 | 29.4× | 2.06e-3 | 1.94e-2 ✓ sig. |
| Carbohydrate digestion and absorption | KEGG | 2 / 48 | 26.3× | 2.56e-3 | 2.28e-2 ✓ sig. |
| Endocrine and other factor-regulated calcium reabsorption | KEGG | 2 / 53 | 23.9× | 3.11e-3 | 2.62e-2 ✓ sig. |
| GnRH secretion | KEGG | 2 / 65 | 19.4× | 4.65e-3 | 3.48e-2 ✓ sig. |
| Gastric acid secretion | KEGG | 2 / 76 | 16.6× | 6.30e-3 | 4.25e-2 ✓ sig. |
| Taste transduction | KEGG | 2 / 86 | 14.7× | 8.01e-3 | 4.96e-2 ✓ sig. |
| Insulin secretion | KEGG | 2 / 86 | 14.7× | 8.01e-3 | 4.96e-2 ✓ sig. |
| GnRH signaling pathway | KEGG | 2 / 93 | 13.6× | 9.31e-3 | 5.43e-2 |
| Salivary secretion | KEGG | 2 / 93 | 13.6× | 9.31e-3 | 5.43e-2 |
| Mineralocorticoid biosynthesis | Reactome | 1 / 6 | 105× | 9.46e-3 | 5.49e-2 |
| Aldosterone synthesis and secretion | KEGG | 2 / 98 | 12.9× | 1.03e-2 | 5.80e-2 |
| Cation-coupled Chloride cotransporters | Reactome | 1 / 7 | 90.3× | 1.10e-2 | 6.03e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| monoatomic ion transport | GO:0006811 | 10 / 667 | 14.7× | 2.17e-10 | 6.12e-8 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 7 / 404 | 17.0× | 8.44e-8 | 1.10e-5 ✓ sig. |
| action potential | GO:0001508 | 4 / 53 | 74.2× | 2.17e-7 | 2.41e-5 ✓ sig. |
| potassium ion transmembrane transport | GO:0071805 | 5 / 150 | 32.8× | 3.31e-7 | 3.45e-5 ✓ sig. |
| potassium ion transport | GO:0006813 | 5 / 152 | 32.4× | 3.54e-7 | 3.64e-5 ✓ sig. |
| transmembrane transport | GO:0055085 | 7 / 557 | 12.4× | 7.43e-7 | 6.73e-5 ✓ sig. |
| cardiac muscle cell action potential involved in contraction | GO:0086002 | 3 / 24 | 123× | 1.78e-6 | 1.38e-4 ✓ sig. |
| neuronal action potential | GO:0019228 | 3 / 34 | 86.8× | 5.23e-6 | 3.28e-4 ✓ sig. |
| sodium ion transmembrane transport | GO:0035725 | 4 / 134 | 29.4× | 9.01e-6 | 5.02e-4 ✓ sig. |
| sodium ion transport | GO:0006814 | 4 / 144 | 27.3× | 1.20e-5 | 6.26e-4 ✓ sig. |
| neuronal action potential propagation | GO:0019227 | 2 / 11 | 179× | 5.36e-5 | 1.94e-3 ✓ sig. |
| neuromuscular process controlling posture | GO:0050884 | 2 / 15 | 131× | 1.02e-4 | 3.14e-3 ✓ sig. |
| nerve development | GO:0021675 | 2 / 19 | 104× | 1.66e-4 | 4.44e-3 ✓ sig. |
| response to auditory stimulus | GO:0010996 | 2 / 23 | 85.5× | 2.45e-4 | 5.86e-3 ✓ sig. |
| membrane depolarization | GO:0051899 | 2 / 32 | 61.5× | 4.77e-4 | 9.23e-3 ✓ sig. |